Submitted by Anonymous (not verified) on 9 July 2025 - 15:22
Human medicines European public assessment report (EPAR): Braftovi, encorafenib, Date of authorisation: 19/09/2018, Revision: 16, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Braftovi, encorafenib, Date of authorisation: 19/09/2018, Revision: 16, Status: Authorised